Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 49, 2004, Pages 17174-17179

  Thompson, R Houston ^a   Gillett, Michael D ^a   Cheville, John C ^a   Lohse, Christine M ^a   Dong, Haidong ^b   Webster, W Scott ^a   Krejci, Kent G ^a   Lobo, John R ^a   Sengupta, Shomik ^a   Chen, Lieping ^c   Zincke, Horst ^a   Blute, Michael L ^a   Strome, Scott E ^a   Leibovich, Bradley C ^a   Kwon, Eugene D ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Costimulation; Immunotherapy; T lymphocyte; Tumor biomarker

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN B7 H1; UNCLASSIFIED DRUG;

ARTICLE; CANCER MORTALITY; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

ANTIGENS, CD; ANTIGENS, CD80; CARCINOMA, RENAL CELL; FOLLOW-UP STUDIES; HUMANS; IMMUNITY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; ODDS RATIO; PEPTIDES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 10344220548     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0406351101     Document Type: Article

References (45)

1. Dong, H., Zhu, G., Tamada, K. & Chen L. (1999) Nat. Med. 5, 1365-1369.
2. Dong, H., Strome, S.-E., Salomao, D.-R., Tamura, H., Hirano, F., Flies, D.-B., Roche, P.-C., Lu, J., Zhu, G., Tamada, K., et al. (2002) Nat. Med. 8, 793-800.
3. Strome, S.-E. & Chen, L. (2004) Curr. Treat. Options Oncol. 5, 27-33.
4. Dong, H. & Chen, L. (2003) J. Mol. Med. 81, 281-287.
5. Strome, S.-E., Dong, H., Tamura, H., Voss, S.-G., Flies, D.-B., Tamada, K., Salomao, D., Cheville, J.-C, Hirano, F., Lin, W., et al. (2003) Cancer Res. 63, 6501-6505.
6. Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T. & Minato, N. (2002) Proc. Natl. Acad. Sci. USA 99, 12293-12297.
7. Curti, B.-D. (2004) J. Am. Med. Assoc. 292, 97-100.
8. Levy, D.-A., Slaton, J.-W., Swanson, D.-A. & Dinney, C.-P. (1998) J. Urol. 159, 1163-1167.
9. Ljungberg, B., Alamdari, F.-I., Rasmuson, T. & Roos, G. (1999) Br. J. Urol. Int. 84, 405-411.
10. Figlin, R.-A., Pierce, W.-C., Kaboo, R., Tso, C.-L., Moldawer, N., Gitlitz, B., deKernion, J. & Belldegrun, A. (1997) J. Urol. 158, 740-745.
11. Yang, J.-C., Sherry, R.-M., Steinberg, S.-M., Topalian, S.-L., Schwartzentruber, A.-J., Hwu, P., Seipp, C.-A., Rogers-Freezer, L. Morton, K.-E., White, D.-E., et al. (2003) J. Clin. Oncol. 21, 3127-3132.
12. Graham, S., Babayan, R.-K., Lamm, D.-L., Sawczuk, I., Ross, S.-D., Lavin, P.-T., Osband, M.-E. & Krane, R.-J. (1993) Semin. Urol. 11, 27-34.
13. Krejci, K.-G., Markiewicz, M.-A. & Kwon, E.-D. (2003) J. Urol. 171, 870-876.
14. Bromwich, E.-J., McArdle, P.-A., Canna, K., McMillan, D.-C., McNicol, A.-M., Brown, M. & Aitchison, M. (2003) Br. J. Cancer 89, 1906-1908.
15. Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H. & Ohtani, H. (2001) Cancer Res. 61, 5132-5136.
16. Couillard, D.-R. & DeVere-White, R.-W. (1993) Urol. Clin. N. Am. 20, 263-275.
17. Cheville, J.-C., Lohse, C.-M., Zincke, H., Weaver, A.-L. & Blute, M.-L. (2003) Am. J. Surg. Pathol. 27, 612-624.
18. Storkel, S., Eble, J.-N., Adlakha, K., Amin, M., Blute, M.-L., Bostwick, D.-G., Darson, M., Delahunt, B. & Iczkowski, K. (1997) Cancer 80, 987-989.
19. Kovacs, G., Akhtar, M., Beckwith, B.J., Bugert, P., Cooper, C.-S., Delahunt, B., Eble, J.-N., Fleming, S., Ljungberg, B., Medeiros, L.-J., et al. (1997) J. Pathol. 183, 131-133.
20. Lohse, C.-M., Blute, M.-L., Zincke, H., Weaver, A.-L. & Cheville, J.-C. (2002) Am. J. Clin. Pathol. 118, 877-886.
21. Therneau, T.-M. & Grambsch, P.-M. (2000) in Modeling Survival Data: Extending the Cox Model (Springer, Ann Arbor, MI), 1st Ed., pp. 87-92.
22. Frank, I., Blute, M.-L., Cheville, J.-C., Lohse, C.-M., Weaver, A.-L. & Zincke, H. (2002) J. Urol. 168, 2395-2400.
23. Dong, H., Zhu, G., Tamada, K., Flies, D.-B., van Deursen, J.-M. & Chen, L. (2004) Immunity 20, 327-336.
24. Wintterle, S., Schreiner, B., Mitsdoerffer, M., Schneider, D., Chen, L., Meyermann, R., Weller, M. & Wiendl, H. (2003) Cancer Res. 63, 7462-7467.
25. Blank, C., Brown, I., Peterson, A.-C., Spiotto, M., Iwai, Y., Honjo, T. & Gajewski, T.-F. (2004) Cancer Res. 64, 1140-1145.
26. Dong, H., Strome, S.-E., Matteson, E.-L., Moder, K.-G., Flies, D.-B., Zhu, G., Tamura, H., Driscoll, C.-L. & Chen, L. (2003) J. Clin. Invest. 111, 363-370.
27. Pantuck, A.-J., Zisman, A. & Belldegrun, A.-S. (2001) J. Urol. 166, 1611-1623.
28. Uzzo, R.-G., Rayman, P., Kolenko, V., Clark, P.-E., Bloom, T., Ward, A.-M., Molto, L., Tannenbaum, C., Worford, L.-J, Bukowski, R.-M., et al. (1999) Clin. Cancer Res. 5, 1219-1229.
29. Nakagomi, H., Pisa, P., Pisa, E.-K., Yamamoto, Y., Halapi, E., Backlin, K., Juhlin, C. & Kiessling, R. (1995) Int. J. Cancer 63, 366-371.
30. Copland, J.-A., Luxon, B.-A., Ajani, L., Maity, T., Campagnaro, E., Guo, H., LeGrand, S.-N., Tamboli, P. & Wood, C.-G. (2003) Oncogene 22, 8053-8062.
31. Lahn, M., Fisch, P., Kohler, G., Kunzmann, R., Hentrich, I., Jesuiter, H., Behringer, D., Muschal, B., Veelken, H., Kulmburg, P., et al. (1999) Eur. Urol. 35, 70-80.
32. Alexander, J.-P., Kudoh, S., Melsop, K.-A., Hamilton, T.-A., Edinger, M.-G., Tubbs, R.-R., Sica, D., Tuason, L., Klein, E., Bukowski, R., et al. (1993) Cancer. Res. 53, 1380-1387.
33. Li, X., Liu, J., Park, J.-K., Hamilton, T.-A., Rayman, P., Klein, E., Edinger, M., Tubbs, R., Bukowski, R. & Finke, J. (1994) Cancer Res. 54, 5424-5429.
34. Kudoh, S., Redovan, C., Rayman, P., Edinger, M., Tubbs, R.-R., Novick, A., Finke, J.-H. & Bukowski, R.-M. (1997) J. Immunol. 20, 479-487.
35. Rini, B.-I., Wwinberg, V. & Small, E.J., (2004) J. Urol. 171, 2115-2121.
36. Motzer, R.-J. (2003) Crit. Rev. Oncol. Hematol. 46S, s33-s39.
37. Hodi, F.-S., Mihm, M.-C., Soiffer, R.-J., Haluska, F.-G., Butler, M., Seiden, M.-V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) Proc. Natl. Acad. Sci. USA 100, 4712-4717.
38. Phan, G.-Q., Yang, J.-C., Sherry, R.-M., Hwu, P., Topalian, S.-L., Schwartzentruber, D.-J., Restifo, N.-P., Haworth, L.-R., Seipp, C.-A., Freezer, L.-J., et al. (2003) Proc. Natl. Acad. Sci. USA 100, 8372-8377.
39. Egen, J.-G., Kuhns, M.-S. & Allison, J.-P. (2002) Nat. Immunol. 3, 611-618.
40. Hofmockel, G., Tsatalpas, P., Muller, H., Dammrich, J., Foot, M., Maurer-Schultze, B., Muller-Hermelink, H.-K., Frohmuller, H.-G. & Bassukas, I.-D. (1995) Cancer 76, 296-306.
41. Tannapfel, A., Hahn, H.-A., Katalinic, A., Fietkau, R.-J., Kuhn, R. & Wittekind, C.-W. (1996) Cancer 77, 164-171.
42. Delahunt, B., Bethwaite, P.-B., Nacey, J.-N. & Ribas, J.-L. (1993) J. Pathol. 170, 471-477.
43. Bui, M.-H., Visapaa, H., Seligson, D., Kim, H., Han, K.-R., Huang, Y., Horvath, S., Stanbridge, E.-J., Palotie, A., Figlin, R.-A., et al. (2004) J. Urol. 171, 2461-2466.
44. Shimazui, T., Oosterwijk, E., Akaza, H., Bringuier, P., Ruijter, E., van Berkel, H., Wakka, J.-O., van Bokhoven, A., Debruyne, F.-M. & Schalken, J.-A. (1998) Clin. Cancer Res. 4, 2419-2424.
45. Uhlman, D.-L., Nguyen, P.-L., Manivel, J.-C., Aeppli, D., Resnick, J.-M., Fraley, E.-E., Zhang, G. & Niehans, G.-A. (1994) J. Natl. Cancer Inst. 86, 1470-1474.